Clinical trial for Parkinson Disease
Official title The Effect of Spinal Mobilization on Respiratory Parameters in Parkinson's Disease Patients
ClinicalTrials.gov ID: NCT04941326
What this study is testing
- What it's testing
- The study wants to find out whether spinal mobilization and diaphragmatic breathing can improve lung function in Parkinson's patients.
- Who it's for
- Adults who have Parkinson's disease and related breathing problems.
- What's involved
- Participants will receive spinal mobilization sessions and learn diaphragmatic breathing, with breathing tests done before and after.
- Time commitment
- The study lasts for the period of the treatment sessions, with a few clinic visits for the therapy and testing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 85
You may be able to join if
- Have been diagnosed with Parkinson's disease
- Volunteering to participate in the study
- Modified Medical Research Council (MMRC) score \>2
You likely can't join if
- Those with COVID-19
- Diseases that increase intra-abdominal pressure
- Diseases affecting diaphragmatic motility
- Those who had a recent thoracic or abdominal operation
- Those who have a parenchymal, pleural or chest wall mass that will cause restriction on a recent chest X-ray or CT will not be included in the study
The study team makes the final eligibility decision.
Where it is enrolling
- Bolu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Bolu, Turkey (Türkiye). Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.